This is not the most recent version of the article. View current version (18 JAN 2012)

Intervention Protocol

Neuromodulators for pain management in rheumatoid arthritis

  1. Bethan L Richards1,*,
  2. Samuel L Whittle2,
  3. Rachelle Buchbinder3

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 19 JAN 2011

Assessed as up-to-date: 7 NOV 2010

DOI: 10.1002/14651858.CD008921

Database Title

Additional Information

How to Cite

Richards BL, Whittle SL, Buchbinder R. Neuromodulators for pain management in rheumatoid arthritis (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD008921. DOI: 10.1002/14651858.CD008921.

Author Information

  1. 1

    Royal Prince Alfred Hospital, Rheumatology, Camperdown, New South Wales, Australia

  2. 2

    The Queen Elizabeth Hospital, Rheumatology Unit, Woodville, South Australia, Australia

  3. 3

    Department of Epidemiology and Preventive Medicine, Monash University, Monash Department of Clinical Epidemiology at Cabrini Hospital, Malvern, Victoria, Australia

*Bethan L Richards, Rheumatology, Royal Prince Alfred Hospital, Missenden Road, Camperdown, New South Wales, 2050, Australia. brichard@med.usyd.edu.au.

Publication History

  1. Publication Status: New
  2. Published Online: 19 JAN 2011

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (18 Jan 2012)

View Full Article (HTML) Full (171K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objectives of this systematic review were to evaluate the analgesic effectiveness of neuromodulators in patients with RA and to evaluate adverse events reported in the clinical trials.

View Full Article (HTML) Full (171K)